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Abstract
Background: Rex1/Zfp42 has been extensively used as a marker for the undifferentiated state of
pluripotent stem cells. However, its function in pluripotent stem cells including embryonic stem
(ES) cells remained unclear although its involvement in visceral endoderm differentiation in F9
embryonal carcinoma (EC) cells was reported.
Results: We showed the function of Rex1 in mouse ES cells as well as in embryos using the
conventional gene targeting strategy. Our results clearly indicated that Rex1 function is dispensable
for both the maintenance of pluripotency in ES cells and the development of embryos. However,
Rex1-/- ES cells showed the defect to induce a subset of the marker genes of visceral endoderm,
when differentiated as embryoid body, as found in EC cells.
Conclusion: Rex1 should be regarded just as a marker of pluripotency without functional
significance like the activity of alkaline phosphatase.
Background
Pluripotency is the differentiation ability of a cell to give
rise all embryonic and adult cell types. Studies of embry-
onic stem (ES) cells have revealed molecular mechanisms
that govern pluripotency involving in both genetic and
epigenetic mechanisms [1,2]. Three transcription factors
Oct3/4, Sox2 and Nanog are regarded as pivotal regulators
because the loss-of-function experiments confirmed their
essential functions for maintenance of pluripotency in ES
cells as well as in peri-implantation development [3-7].
Moreover, the gain-of-function experiments emphasize
their function associated to pluripotency. Nanog overex-
pression supports self-renewal of mouse ES cells in the
absence of leukemia inhibitory factor (LIF) and promote
imposition of pluripotency on somatic cells after cell-
fusion with ES cells [8,9], whereas ectopic expression of
Oct3/4 and Sox2 with additional two transcription factors
Klf4 and cMyc is sufficient to induce pluripotency in
embryonic and adult fibroblast cells [10]. Oct3/4 co-oper-
ates with Sox2 to activate transcription of the target genes
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Generation of ES cells with various Rex1 genotypesFigure 1
Generation of ES cells with various Rex1 genotypes. A. Strategy for generation of Rex1-KO ES cells. The schematic 
maps of the Rex1 allele (top), the KO vector carrying the floxed pacEGFP-pA cassette (middle), and the KO allele generated by 
homologous recombination (bottom) were shown in scale. The EcoRI sites (E) provide the polymorphism between the wild-
type and mutant alleles, 8.0 kb and 2.4 kb, respectively, on southern blot analysis using the indicated 3' external probe. B. 
Southern blot hybridization of wild-type (+/+), Rex1 heterozygous (+/-) and homozygous (-/-) ES cells using the EcoRI digestion 
and the 3' external probe. The expected sizes of wild-type (wt) and mutant (mut) bands were detected. The 5.6 kb fragment 
corresponds to the polymorphism of the Rex1 pseudogene on chromosome 15 reported previously as well as found in the 
mouse genome data. C. Northern blot analysis of Rex1 expression in wild-type (+/+), Rex1 heterozygous (+/-) and homozygous 
(-/-) ES cells. The Rex1 cDNA probe detects 1.8 kb mRNA from the wild-type allele and 3.5 kb mRNA, which is generated by 
inefficient function of the polyA addition signal in the pacEGFP-pA cassette, from the mutant allele. The Rex1 KO ES cells lack 
the wild-type transcript. D. Northern and western blot analysis of wild-type (+/+) and Rex1 KO (-/-) ES cells with the Rex1 
transgene (Tg:+) or the empty vector (Tg:-). The 2.7 kb transcripts from the transgene were detected with or without the 2.2 
kb endogenous transcripts in Northern blot with the Rex1 cDNA probe (top), in which equal loading of total RNA was con-
firmed by ethidium bromide staining of 28S and 18S ribosomal RNAs (middle). Western blot using anti-Rex1 antisera detects 
~38 kd band in wild-type, wild-type+Tg and Rex1 KO+Tg lanes but not Rex1 KO lane (bottom), confirming the proper produc-
tion of Rex1 protein from Tg. E. QPCR analysis of Rex1 expression in undifferentiated (+LIF) and differentiated (-LIF and EB) 
ES cells with various Rex1 genotypes. Three independent clones with each genotypes were cultured with or without LIF for 4 
days or for formation of EBs for 5 days, analyzed separately with normalization by the amount of Gapdh, and plotted with 
standard deviation against the expression level in undifferentiated wild-type ES cells (wt) cultured with LIF, set as 1.0. The 
primer pair was set in the region deleted in the KO allele.
BMC Developmental Biology 2008, 8:45 http://www.biomedcentral.com/1471-213X/8/45including Oct3/4 [11], Sox2 [12] and Nanog [13]. It has
been recently shown that Sox2 is essential to maintain
expression of Oct3/4 in ES cells [7], suggesting that these
three transcription factors form a network to maintain
pluripotency.
In addition to Oct3/4, Sox2 and Nanog, other putative
transcription factors expressing pluripotent stem cells in
stem-cell-specific manner have been identified. Rex1 (for
reduced expression-1, also known as Zfp42) was first iden-
tified a gene that expresses in F9 embryonal carcinoma
(EC) cells and is down-regulated after retinoic acid (RA)
treatment to induce differentiation [14]. This gene
encodes a C2H2 zinc-finger protein that is closely similar
to Yy1, an evolutionally-conserved component of poly-
comb-related complex 2 [15]. Its highly-specific expres-
sion in pluripotent stem cells has been confirmed in
mouse and human ES cells [16,17], making it one of the
most famous markers of pluripotency tested in various
stem cells such as multipotent adult progenitor cells [18]
and amniotic fluid cells [19]. However, its function in ES
cells has not yet been characterized well although it has
been reported that a targeted deletion of Rex1 results in
loss of the ability to differentiate into visceral endoderm
induced by RA in F9 EC cells [20], and that a gene silenc-
ing by RNA interference for Rex1 results in loss of capacity
to self-renew in ES cells [21].
In this paper, we report our results of functional assay of
Rex1 in ES cells as well as in embryos. Over-expression of
Rex1 in ES cells neither induces differentiation in the pres-
ence of LIF nor maintains self-renewal in the absence of
LIF. Rex1-/- ES cells can be established and contribute
whole embryos after blastocyst injection, indicating that
they possess proper pluripotency. Rex1-/- mice were pro-
duced by the intercross of heterozygotes, and both male
and female homozygotes were normal and fertile. Our
data proofed that Rex1 is dispensable for maintenance of
pluripotency beyond the shadow of a doubt.
Results
Generation of gain- and loss-of-function mutant ES cell 
lines for Rex1
To analyze the precise function of Rex1 in the mainte-
nance of pluripotency, we generated a series of geneti-
cally-engineered ES cell lines for its gain- and loss-of
function analyses. For loss-of-function analysis, we dis-
rupted the endogenous Rex1 allele by conventional gene
targeting via homologous recombination in ES cells (Fig.
1A). The knock-out (KO) allele should be a functionally
null allele because the first 100 bp of the open reading
frame in the exon 4 including the start codon was replaced
by the pacEGFP chimeric gene cassette containing the
puromycin-resistant gene (pac) and the green fluorescent
protein (Egfp) cDNA. Interestingly, all of the puromycin-
resistant clones obtained by transfection of this KO vector
carried the correctly targeted alleles. One of the Rex1+/- ES
cell line (RKPG9) was cultured with high-dose puromycin
to obtain the Rex1-/- ES cell lines generated via spontane-
ous gene conversion. As the result, multiple Rex1-/- ES cell
lines were established with extremely high efficiency (4 of
4 clones obtained after the selection were homozygous for
Rex1 KO allele). Correct targeting events were confirmed
by the loss of the polymorphic signature of the wild-type
allele on the southern blot analysis of the genomic DNA
(Fig. 1B), in which the 5.6 kb fragment corresponds to the
Rex1 pseudogene on chromosome 15 reported previously
as well as found in the mouse genome data [22]. Northern
blot revealed the loss of the transcript derived from the
wild-type allele in Rex1-/- ES cells, which express the large
transcripts composed by the truncated Rex1 and pacEGFP
(Fig. 1C). Rex1-/- ES cells were also established by intro-
duction of the second knockout vector carrying the hygro-
mycin-resistant gene as a selection marker into Rex1+/- ES
cells with pacEGFP followed by the selection with hygro-
mycin B. Genotyping of 5 drug-resistant clones revealed
that 2 clones were Rex1+/- and 3 clones were Rex1-/-, indi-
cating that Rex1-/- ES cells were able to be established
without selection pressure (data not shown). Easy isola-
tion of the Rex1-/- ES cells suggested that the Rex1 func-
tion is not essential for self-renewal of ES cells.
For gain-of-function assay for Rex1, the Rex1 cDNA iso-
lated from ES cell RNA by RT-PCR was inserted into the
expression vector pCAG-IZ [23] and introduced into the
wild-type and the Rex1-/-ES cells. Since the strong activity
of the CAG expression unit [24], the bi-cistronic design of
the expression vector with internal ribosome entry site
(IRES) [25] and the character of the zeocin selection sys-
tem, in which high level expression of the zeocin-resistant
gene (zeo) is required for the host cells to survive in the
medium containing 40 µg/ml of zeocin [26], all of the
resulting transfectants express Rex1 cDNA at comparative
or higher level to that of the endogenous Rex1 gene in the
wild-type ES cells. Since the efficiency to obtain the
zeocin-resistant clones was not different between wild-
type and Rex1-/-ES cells, the over-expression might not
affect self-renewal of ES cells (data not shown).
As the results of these gene manipulations, we established
ES cell lines with four different genotypes for Rex1; ES cells
carrying the wild-type Rex1 alleles and the empty CAG-IZ
vector (wt), the wild-type Rex1 alleles and the Rex1 trans-
gene (wt-Tg), the Rex1-/- alleles and the empty vector
(KO), and the Rex1-/- alleles and the Rex1 transgene (KO-
Tg). Since the Rex1-Tg express Rex1 at twice levels of the
endogenous Rex1, the wt-Tg ES cell lines express Rex1 at
three times more than the wild-type ES cells as the sum of
endogenous and exogenous transcripts, whereas the KO-
Tg lines express at the twice levels of the wt ES cells (Fig.Page 3 of 12
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wt ES cells from the constitutively-active transgene irre-
spective to the culture condition, whereas the endogenous
Rex1 gene is down-regulated immediately after induction
of differentiation by either withdrawal of leukemia inhib-
itory factor (LIF) or formation of embryoid bodies (EBs)
(Fig. 1E).
Minor effects of Rex1 on the pluripotency-associated 
transcriptome
First we tested Rex1-dependent transcription in ES cells
since the Rex1 protein may function as a transcription fac-
tor like its most homologous protein Yy1. Indeed, we con-
firmed that the chimeric Rex1 proteins with Egfp-tag and
HA-tag localize in nuclei (Fig. 2). One of the important
functions of Yy1 is mediated by the interaction with the
polycomb related complexes (PRCs) [27], and it was
reported that Yy1 directly interact to PRCs and recruit
them to the targets in sequence-specific manner [28].
Recently, the functional importance of PRCs in ES cells to
repress differentiation-related genes has been disclosed
[1]. Gene expression profiles were qualitatively examined
by the microarray analyses of two Rex1-/- ES cells (HP3
and HP4), and one wild-type ES cells (EB5), revealing that
very few genes showed significant differences in their
expression levels between wild-type and Rex1-/- ES cells
(Fig. 3A). A pair-wise comparison of Rex1+/+ ES cells
(EB5) and Rex1-/- ES cells (HP3) (false discovery rate
(FDR) < 0.05, gene expression difference > 2-fold) showed
only 116 genes whose expression levels were significantly
different. Among them, 30 genes were up-regulated in
Rex1-/- ES cells (Additional file 1), whereas 86 genes were
down-regulated (Additional file 2). To verify the relation-
ship between the expressions of these genes and the Rex1
genotypes, we quantified the expression levels in each
three wt, wt+Tg, KO and KO+Tg ES cell lines by quantita-
tive RT-PCR (QPCR). As a result, 3 genes (Mylpf, Lgals1
and Dusp14) were identified as putative Rex1 target genes
Nuclear localization of Rex1Figure 2
Nuclear localization of Rex1. The expression vectors of EGFP-tagged or HA-tagged Rex1 were transiently transfected into 
HeLa and ES cells, and the localization of these transgene products were detected by fluorescent microscopy directly (for 
EGFPRex1) or after immunostaining for HA-tag (for HARex1). Phase contrast (left), fluorescent (middle) and their merged 
image (right) were shown for each transfectants. The fluorescent signals were localized in nuclei in both HeLa and ES cells for 
both chimeric Rex1 proteins.Page 4 of 12
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cells, which were restored in KO-Tg ES cells (Fig. 3B).
These data suggested that Rex1 may functions as a tran-
scription factor although its impact on the maintenance of
the pluripotency-assocoated transcriptome is very faint.
Rex1 does not involve in the maintenance of pluripotency 
in ES cells
Using three independent clones each of the ES cell lines
with 4 genotypes shown above (wt, wt-Tg, KO and KO-
Tg), we tested the function of Rex1 in both dominant and
recessive manners in the maintenance of pluripotency in
ES cells. All ES cell lines propagated at the comparable
growth rate and kept normal morphology (Fig. 4A). Gene
expression analysis by QPCR revealed no remarkable
change among them for several pluripotency-associated
markers such as Oct3/4 and Nanog (Fig. 4C and data not
shown). All these ES cells completely undergo morpho-
logical differentiation for 5 days after withdrawal of LIF
(Fig. 4A) with accompanying the up-regulation of a set of
primitive endoderm markers such as Gata4 [29], Gata6
[30] and Disabled homolog 2 (Dab2) [31] (data not
shown). There was no difference in the kinetics of differ-
entiation event although the slight increase of Nanog
expression was evident in wt-Tg ES cells (Fig. 4C). There-
fore, Rex1 is incapable to maintain LIF-independent self-
renewal either in dominant manner like the case of Nanog
[8] or the recessive manner like the case of Mbd3 [32].
Next we tested the function of Rex1 in ES cells in relation
to PRCs. It was reported that targeted deletion of the PRC2
component Eed resulted in reduced ability of differentia-
tion [33], and that of Suz12 caused delayed down-regula-
tion of the pluripotency-assocoated markers during
formation of embryoid bodies (EBs) [34]. To test the anal-
ogous function of Rex1, we generated EBs from wt, wt-Tg,
KO and KO-Tg ES cells and analyzed the expression pat-
tern of the various marker genes. The growth and mor-
phology of EBs were indistinguishable among these ES
cells (Fig. 4A), indicating that the differentiation ability of
KO ES cells was obviously unaffected and persistent
expression of Rex1 from the constitutively-active Tg does
not affect differentiation event in this context. Moreover,
induction of the primitive endoderm markers Gata4,
Gata6 and Dab2 occurred normally in these EBs irrespec-
tive to their Rex1 genotypes (Fig. 4B), and the down-regu-
lation of the pluripotency-assocoated markers Oct3/4 and
Nanog was also unaffected (Fig. 4C). These data as well as
the gene expression profile suggested that Rex1 function
does not involve in global PRC recruitment in ES cells.
Aberrant induction of some visceral endoderm markers in 
the absence of Rex1
According to the previous analysis of Rex1-/- F9 EC cells,
Rex1 might involve in differentiation of visceral endo-
derm [20]. In the case of ES cells, visceral endoderm is effi-
ciently imaged on the surface of EBs [35]. Therefore, we
Gene expression profile in Rex1 KO ES cellsFigur  3
Gene expression profile in Rex1 KO ES cells. A. DNA microarray analysis of Rex1 KO ES cells. Scatter-plot of log-ratios 
of relative expression levels were shown for wild-type (EB5) versus Rex1 KO (HP3) ES cells. B. QPCR analyses of expressions 
of the putative Rex1 target genes. Three independent clones with each genotypes were cultured with LIF for 4 days, analyzed 
separately with normalization by the amount of Gapdh, and plotted with standard deviation against the expression level in 
undifferentiated wild-type ES cells (wt), set as 1.0.Page 5 of 12
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analyzed the induction of extraembryonic endoderm
marker genes. The growth and morphology of EBs were
indistinguishable among these ES cells (Fig. 4A). How-
ever, the induction of two visceral endoderm marker
genes, Transthyretin (Ttr) [35] and Indian hedgehog (Ihh)
[36], were reduced in EBs derived from KO ES cells, which
were restored in KO-Tg ES-derived EBs, indicating that this
phenotype is depend on the expression of Rex1 (Fig. 4B).
Interestingly, the induction level of the Sry-related tran-
scription factor Sox7, which also expresses in visceral
endoderm in vivo [37], was also reduced in KO ES-derived
EBs and restored in KO-Tg ES-derived EBs, suggesting its
involvement in visceral endoderm differentiation. How-
ever, the visceral endoderm differentiation might not
completely perturbed in the absence of Rex1 because
Alphafetoprotein (Afp), which is an archetypal marker for
visceral endoderm [38], was normally induced in EBs
derived from KO ES cells (Fig. 4B). In contrast, the parietal
endoderm markers Sparc (secreted acidic cysteine rich glyco-
protein) [39] and Plat (tPA; plasminogen activator, tissue)
[40], were equally induced in EBs irrespective to their gen-
otypes for Rex1 (Fig. 4B). These data indicated that Rex1
function might specifically involve in the differentiation
of visceral endoderm.
Rex1 function in vivo
To fully evaluate the differentiation ability of the Rex1-/-
ES cells, we labeled these cells by introduction of the con-
stitutively-active Egfp transgene (CAG-Egfp-IZ) and
injected them into blastocysts followed by transplanta-
tion in uteri of pseudo-pregnant mice to generate chimeric
embryos. As a result, we obtained the embryos with wide-
spread contribution of the fluorescent cells derived from
Differentiation of ES cells with various Rex1 genotypesFigu  4
Differentiation of ES cells with various Rex1 genotypes. A. Photomicrographs of colonies at 4 days cultured with LIF 
(left) or without LIF (middle), or EBs at 5 days (right) derived from representative ES cells with indicated genotypes for Rex1. 
Scale bar is 100 µm. B. QPCR analyses of the endoderm marker genes in EBs derived from ES cells with various Rex1 geno-
types. Three independent clones with each genotypes were cultured for formation of EBs for 5 days, analyzed separately with 
normalization by the amount of Gapdh, and plotted with standard deviation against the expression level in wild-type ES cells-
derived EBs, set as 1.0. C. QPCR analyses of the stem cell marker genes in ES cells and EBs with various Rex1 genotypes. Three 
independent clones with each genotypes were cultured for 4 days with LIF or for formation of EBs for 5 days, analyzed sepa-
rately with normalization by the amount of Gapdh, and plotted with standard deviation against the expression level in wild-type 
ES cells, set as 1.0.Page 6 of 12
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pluripotent (Fig. 5).
In the chimeric embryos, all extra-embryonic tissues were
derived from the host blastocysts, so the deficiency of vis-
ceral endoderm formation of the Rex1-/- cells in develop-
ment should be uncovered. To test this point, we
generated the mice carrying the null allele for Rex1 by the
mating of the male chimeras generated from the heterozy-
gote ES cells with the wild-type female mice. The resulting
heterozygotes were obviously normal and healthy, and
their intercross resulted in generation of the homozygotes
for the Rex1-null allele. Although the ratios of the hetero-
zygotes and homozygotes were smaller than the expected
mendelian ratios in the offsprings at 8 weeks (Table 1),
both homozygous males and females were fertile and
showed no morphological abnormalities. Indeed, the
homozygous offsprings were obtained by the intercross of
the homozygotes, indicating that the Rex1 gene show nei-
ther the maternal effect nor the critical role in the develop-
ment of the extraembryonic tissues including visceral
endoderm. When we analyzed genotypes of embryos at
17.5 dpc, no significant reduction of heterozygotes and
homozygotes was observed (Table 2), suggesting that the
loss of embryos with these genotypes occurred peri- or
post-natal period. Although the reason of this phenome-
non is still unclear, these data indicated that the Rex1
function is dispensable for the maintenance of pluripo-
tency in the early developmental period as well as the
germ cell development in the mid and late developmental
periods.
Discussion
Cell-type-specific gene expression is one of the important
landmarks of gene function in development. In ES cells,
microarray analysis, SAGE and in silico subtraction of EST
database have been identified several genes specifically
expressing in undifferentiated ES cells. Among them, Rex1
is one of the oldest marker genes of undifferentiated
pluripotent stem cells first reported on 1989 [14]. Since
then, the function of Rex1 has been kept as a mystery, but
here we finally revealed its dispensability to maintain cel-
lular pluripotency.
Rex1 was first identified as the gene which expression is
repressed by RA in F9 EC cells. A deletion of Rex1 from F9
cells resulted in the loss of ability to differentiate into vis-
ceral endoderm induced by RA and cyclic AMP analogs
without no phenotypical change in their undifferentiated
state [20], which is consistent with our result shown here.
In contrast, it was recently reported that RNAi-mediated
silencing of Rex1 in ES cells prevents self-renewal [21].
The controversy between the phenotypes of gene-targeting
and gene-silencing might be derived from the different
kinetics of silencing or the strong bias of the selection of
homozygous mutant ES cells that allow establishment of
adopted ES cells for the absence of the particular gene
function. Although both might be the case for Rex1, nei-
ther ES cells nor mouse embryos show any phenotype in
the maintenance of pluripotency, suggesting that the
imperfect target specificity of gene-silencing by RNAi
might be most responsible to give the discrepancy in this
case since the expression vector to generate large double-
strand RNA was applied in the above report.
Why does the function of Rex1 revealed here look so
minor although the previous reports suggested its impor-
tance in ES cells as the common target of the pluripotency-
associated transcription factors Oct3/4, Sox2 and Nanog
[22,41-43] as well as the component of the protein-inter-
action network [44]? One simple explanation is func-
tional redundancy between Rex1 and its related gene(s)
present in the genome. Rex1 encodes the C2H2-type zinc-
finger whose sequence is most similar to the transcription
factor Yy1 [45]. Yy1 widely expresses in various tissues in
embryos and adults and its function is essential for peri-
implantation development [46]. Since Rex1 express in
inner cell mass of the blastocyst-stage embryos and its
expression is down-regulated after implantation [16,47],
the pre-implantation development of Yy1-null embryos
might be supported by the overlapped function of Rex1
and its down-regulation after implantation might cause
their lethality. The function of Yy1 is pleiotropic [15] and
one of them is the function to recruit PRCs to the specific
target sequences to repress the transcription of the target
genes [27,28]. Although the several reports showed the
function of the polycomb complex for the maintenance of
Chimeric embryos derived from Rex1 KO ES cellsFigure 5
Chimeric embryos derived from Rex1 KO ES cells. 
When HP4-EGFP ES cells, which were homozygotes for the 
mutant Rex1 allele and marked by the constitutively-active 
Egfp transgene, were injected into blastocysts, the embryos 
developed to chimeras at 12.5 dpc in which widespread con-
tributions of GFP-positive cells were observed in fluorescent 
microscopic observation.Page 7 of 12
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tent stem cells has yet been confirmed. Since Yy1 expresses
in ES cells, it may mask the phenotype of the Rex1-/- ES
cells by the functional redundancy. It was recently
reported that Rex1 is a pseudogene generated from Yy1 by
retrotransposition [45]. The zinc-finger domain of Yy1 is
encoded by 3 exons whereas that of Rex1 is encoded in a
single exon, and Yy1 is evolutionally conserved in all ver-
tebrates, whereas Rex1 is found only in placental mam-
mals. This hypothesis suggests that Yy1 occupies the major
role in the redundant function to Rex1 and vice versa. The
specific function of Rex1 to induce particular markers in
visceral endoderm might be conducted by its different
preference of the target sequence from Yy1 [45] or down-
regulation of Yy1 in this cell type.
The most prominent phenotype of the Rex1 deficiency is
the poor induction of a subset of visceral endoderm
marker genes. In the case of F9 EC cells, the null mutation
for Rex1 completely prevent differentiation of visceral
endoderm induced by RA and cAMP analogs, which was
evaluated by the complete loss of induction of one of the
visceral endoderm markers, Afp. In contrast, in ES cells,
the suspension culture allows induction of visceral endo-
derm without any small molecule inducers, and the loss
of Rex1 affects the induction of Ttr and Ihh, but not Afp.
How can the Rex1 deficiency modulate the expression of
the visceral endoderm marker genes although its expres-
sion is tightly restricted in pluripotent stem cells and
down-regulated during their differentiation (Fig. 1E and
[16,47])? One possible explanation is that the gene(s)
expressing in the pluripotent stem cells under the control
of Rex1 might induce the gene(s) in the visceral endoderm
adjacent to them in EBs like the case of Fibroblast growth
factor-4 (Fgf4), which is produced by the pluripotent stem
cells and acts as a paracrine growth factor for the extra-
embryonic endoderm cells and the trophectoderm cells
[48]. However, the functional significance of the reduced
levels of these visceral endoderm markers associated to
the Rex1 deficiency should be very minor because the
Rex1-null embryos are absolutely capable to develop nor-
mally in early embryogenesis.
It is a surprise that this is the first report of the Rex1 knock-
out mice because this gene was discovered 18 years ago,
has been regarded as an important marker of pluripotent
stem cells, and the generation of the heterozygous ES cell
line via gene-trap was reported in 1992 [49]. The cell-type-
specific expressions of genes have been regarded as good
landmarks of their functions. Indeed, Oct3/4 and Nanog
show highly specific expression in pluripotent stem cells
in vitro as well as in vivo and exhibit essential function to
maintain pluripotency. However, there are several excep-
tions of this relationship in the genes specifically express
in pluripotent stem cells. In the cases of Fbxo15, Sox15 and
Dppa5/Esg1, the null mutant embryos for them show no
abnormality and the null ES cells are capable to be estab-
lished and maintained although their expression is as
tightly restricted in pluripotent stem cells as the case of
Oct3/4 [50-52]. The discrepancy between the specific
expression and the function in pluripotent stem cells
might due to the global down-regulation of gene expres-
sion during differentiation of pluripotent stem cells via
epigenetic mechanism. It was discovered that the epige-
netic repression of gene expression is quite loose in the
pluripotent stem cells, which is established during their
differentiation [2]. In addition, the cell-cycle regulation is
also dramatically altered during differentiation since the
S-phase is enriched in ES cells whereas the G1 phase is
predominant in differentiated cells [53]. Therefore, no
specific transcriptional regulation might be required for
genes to exhibit the stem-cell-specific expression pattern
especially if their expressions depend on the cell-cycle.
Indeed, in the case of Rex1, the octamer motif for the
binding of Oct3/4 identified in the mouse Rex1 promoter
[22,41] is not conserved in the human Rex1 promoter
based on the Ensembl database search, although the pre-
vious reports confirmed that both are capable to direct
stem-cell-specific transgene expression [17], suggesting
Table 1: Genotype analysis of progeny resulting from crosses of Rex1 +/- mice
No. of mice with indicated genotype (% of total)
+/+ +/- -/- Total No. of mice
Female 21 26 5 52
Male 22 23 9 54
Total 43 (40.6) 49 (46.2) 14 (13.2) 106 (100)
Table 2: Genotype analysis of fetus at 17.5 dpc resulting from 
crosses of Rex1 +/- mice
No. of mice with indicated genotype (% of total No)
+/+ +/- -/- Total No. of mice
8 18 9 35
(23) (51) (26) (100)Page 8 of 12
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for its stem-cell-specific expression.
This is not the end of the story of Rex1, however. The inter-
cross of the Rex1 heterozygotes revealed mild reduction of
the homozygous pups between 17.5 dpc and 8 weeks after
the birth. Although the reason of this lethality with low
penetrance is completely mysterious since the expression
of Rex1 is only detectable in the germ cells at the late-stage
embryos and the pups, Rex1 should have some function
apart from the pluripotent stem cells, which is out of our
scope of the research. We hope the Rex1 mutant mice
strain we generated will be applied for the further studies
to unlock the mystery of the Rex1 function in the differen-
tiated cell lineage.
Conclusion
We showed that Rex1 function is dispensable for self-
renewal of mouse ES cells. Although its possible function
in pluripotent cells in particular developmental context
has not been ruled out completely, its function is not
required to maintain pluripotency in its conventional
meaning.
Methods
Cell culture and transfection
E14tg2a [54] and its derivatives appear in this paper were
cultured in the absence of feeder cells in Glasgow minimal
essential medium (GMEM) supplemented with 10% fetal
calf serum, 1 mM sodium pyruvate, 1× nonessential
amino acids, 10-4 M 2-mercaptoethanol, and 1000 U of
leukemia inhibitory factor (LIF) per ml on gelatin-coated
dishes. For the transfection, 107 ES cells were electropo-
rated with 50 µg of linealized plasmid DNA at 800 V and
3 µF in a 0.4-cm cuvette using a Gene Pulser (Bio-Rad) fol-
lowed by the culture with appropriate selection drugs (1.5
µg/ml of puromycin [Sigma] or 40 µg/ml of zeocin [Invi-
vogen]) for 7 to 10 days. For the selection of Rex1-/- ES
cells, the heterozygous mutant ES cells were cultured in
the presence of 9 µg/ml of puromycin in the first 3 days.
HeLa cells were cultured in GMEM supplemented with
10% FCS. For transient expression of EGFP-Rex1 and HA-
Rex1, 2 µg of plasmid DNA was transfected into 3 × 104
cells using Lipofectoamine 2000 (Invitrogen).
For induction of differentiation, 2 × 104 cells were seeded
in 60-mm dish in the presence or absence of LIF and cul-
tured for 4 days, or 300 cells were cultured in 15 µl of
hanging drop in the ES culture medium without LIF for 5
days to generate embryoid body (EB).
Construction of KO vector and expression vectors
For generation of Rex1-KO vector, the genomic DNA frag-
ment for 5' and 3' homology arms were amplified from





tively. The 4.2 kb of 5' homology arm was sub-cloned into
the EcoRV site of pBlKS(-) then excised by SalI and SpeI,
and the 3' homology arm was digested by SpeI and NotI.
These DNA fragments were subcloned into SalI and NotI
of pBlKS(-), resulting pRex1 5'+3'. The pacEGFP-pA cas-
sette carrying the fusion gene of puromycin acetyltransferase
(pac) and Egfp (HN, unpublished) was inserted into Hin-
dIII-BamHI between the loxP sites of pBS246 (Life Tech-
nologies), and the SpeI-EcoRI fragment with loxP-
pacEGFP-pA-loxP was inserted into SpeI-EcoRI of pRex1
5'+3', resulting pRex1-KO. The 300 bp fragment of
genomic DNA at 3' external region of the Rex1 KO vector,
which was amplified using the primers 5'-
TGGGGACTTTTGCATACGGCAG-3' and 5'-GAACTCATT-
TCTAGTGTTTTATTTTC-3' and subcloned into the EcoRV
site of pBlKS(-), was used as a probe for southern blot
analysis of the homologous recombinants.
The Rex1 expression vector was constructed by inserting
the Rex1 cDNA amplified from cDNA of E14tg2a ES cells
using the primers 5'-GACATCATGAATGAACAAAAAATG-
3' and 5'-CCTTCAGCATTTCTTCCCTG-3' into the BstXI
sites of pCAG-IZ [26] using the BstXI adaptors. For gener-
ation of the expression vectors of EGFP-Rex1 and HA-
Rex1, the BspHI-NotI fragment of pCAG-Rex1-IZ was
excised and introduced into NcoI-NotI of pCAG-
EGFPOct3-IP and pCAG-HAOct3-IP [23], respectively.
Immunoblotting and immunohistochemistry
The whole cell lysates were fractionated on sodium
dodecyl sulfate (SDS)-10% polyacrylamide gel and elec-
troblotted onto a polyvinylidene difluoride membrane.
After treatment in blocking buffer (1× TTBS [10 mM Tris
HCl {pH 7.4}, 137 mM NaCl, 2.7 mM KCl, 0.1% Tween
20] plus 3% skimmed milk), membrane was probed with
the rabbit anti-Rex1 antisera raised against the GST-Rex1
fusion protein and then horseradish peroxidase-conju-
gated anti-rabbit immunoglobulin G antibody and devel-
oped using ECL reagents (GE Healthcare). For the
detection of HA-Rex1 in the transient transfectants, 24
hours after transfection of pCAG-HA-Rex1-IP, the cells
were fixed by 4% paraformaldehyde in phosphate-buff-
ered saline (PBS) for 30 minutes at 4°C and then permeal-
ized by 0.2% Triton X-100 in PBS for 15 minutes at room
temperature. After brief washing with PBS followed by
blocking by 2% FCS in PBS, the cells were stained with
mouse anti-HA antibody (clone 262 K; Cell Signaling
Technology) and then Alexa Fluor 488-conjugated goat
anti-mouse antibody (Molecular Probes). The fluorescent
images were captured with an IX51 microscope (Olym-
pus) and DP70 digital camera (Olympus).Page 9 of 12
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Total RNA was prepared using TRIzol reagent (Invitrogen)
or QUICKGene RNA cultured cell kit (FUJIFILM) accord-
ing to the manufactures' instructions. For Northern blot
analysis, 4 µg of total RNA was analyzed by non-radioac-
tive filter hybridization (Gene Image; GE Healthcare) with
either the Rex1 cDNA probe (probe N1) or the Rex1 cDNA
fragment probe hybridize to the region deleted in the KO
allele (for probe N2). First strand cDNA was synthesized
from 1 µg of total RNA in 40 µl of the reaction mixture
containing oligo-dT primers using a ReverTra Ace first
strand synthesis kit (Toyobo). Real-time PCR was per-
formed with the ExTaq cyber green supermix (Takara)
using an iCycler System (Bio-Rad). The amount of target
RNA was determined from the appropriate standard
curve, and was normalized relative to the amount of
Gapdh mRNA. Sequences of primer pairs were described
previously [55] as well as shown below.
Rex1; forward 5'-ttgcctcgtcttgctttagg-3' and reverse 5'-
aaaatgaatgaacaaatgaagaaaa-3', Mylpf; forward 5'-gcccccag-
gagatctaagac-3' and reverse 5'-ccactggcttccttcatcat-3',
Lgals1; forward 5'-ctctcgggtggagtcttctg-3' and reverse 5'-
gcgaggattgaagtgtaggc-3', Dusp14; forward 5'-gaagatcaag-
ggcagctcag-3' and reverse 5'-tcccagggcacactaatttc-3'.
Microarray analysis
DNA microarray analyses were performed as described
previously [56], using an NIA Mouse 22 K Microarray v1.1
(manufactured by Agilent Technologies: #11472,
G4120A), which contained the genes listed at the
National Institute of Aging mouse cDNA project web site
http://lgsun.grc.nia.nih.gov/cDNA/cDNA.html. Briefly, 5
µg of total RNA was transcribed into double-strand T7
RNA polymerase-tagged cDNA and amplified into single-
stranded, fluorescence-tagged cRNA by T7 polymerase.
The samples for wild-type (EB5) and Rex1-/- (HP3, HP4)
ES cells were hybridized against a universal reference RNA
at 60°C on the DNA microarrays. After washing, microar-
rays were scanned with an Agilent DNA Microarray Scan-
ner. Microarray results were analyzed using NIA Array
Analysis Software [57]. Complete array data will be avail-
able on the GEO (NCBI) website.
Production of chimeric embryos and mice
To visualize the in vivo contribution of Rex1-/- ES cells,
HP4 ES cells were transfected with the constitutive Egfp
expression vector (pCAG-Egfp-IZ), resulting establish-
ment of HP4-EGFP ES cells. To obtain chimeric embryos,
HP4-EGFP ES cells were injected into C57Bl/6J blasto-
cysts, followed by transfer into the uteri of pseudopreg-
nant ICR mice. Embryos were dissected at 12.5 dpc and
fluorescent signals were detected using an Olympus
SZX12 fluorescent dissecting microscope and captured
with an Olympus DP70 digital Camera.
To establish the mouse strain carrying the mutated Rex1
allele, heterozygous ES cells were injected into C57Bl/6J
blastocysts to generate chimeric mice. Male germline chi-
mera was crossed with C57Bl/6J females to obtain hetero-
zygous litters, in which the transmission of the mutated
Rex1 allele was monitored by southern blot using the 3'
external probe. These heterozygotes were intercrossed for
generation of homozygotes, and the homozygotes were
mated to confirm their fertilities.
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